Single Intramuscular Dose of Nirsevimab Reduces Likelihood of Hospitalization Due to RSV in Average-Risk Infants During First Year of Life

• 2024

  Log in to bookmark this resource.

  Log in
• Mark Ebell
PMID: 38804769

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This article addresses the clinical question of using a single injection of nirsevimab to reduce respiratory syncytial virus (RSV) hospitalization in average-risk infants who don't qualify for palivizumab. The study focused on average-risk infants in their first year of life. Nirsevimab has been tested in other studies and is considered helpful for preventing RSV in both preterm and healthy late-preterm babies. The research highlights its potential to reduce illness caused by RSV among young children, offering hope for better protection against this virus.

---

Tags

Focus Area: Infectious Disease

Audience: Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Antiviral Agents; Hospitalization; Infant; Injections, Intramuscular; Respiratory Syncytial Virus Infections; Antibodies, Monoclonal, Humanized

Institutions: University of Georgia

---

More like this

Impact of the COVID-19 Pandemic on Parental Stress and Young Children’s Development During Physical Distancing 2020 · Natural Hazards Center, Georgia State University, Weber State University Safety of Re-dosing Nirsevimab Prior to RSV Season 2 in Children With Heart or Lung Disease 2023 · State University of New York - Upstate Medical University, AstraZeneca, Dr. Georgi Stranski University Hospital, Quironsalud Madrid University Hospital, Fukuoka Children's Hospital, Hôpital Femme-Mere-Enfant Efficacy of Nirsevimab Against Respiratory Syncytial Virus Lower Respiratory Tract Infections in Preterm and Term Infants, and Pharmacokinetic Extrapolation to Infants With Congenital Heart Disease and Chronic Lung Disease: A Pooled Analysis of Randomised Controlled Trials 2023 · Children's Hospital Colorado, University of the Witwatersrand, Northwestern University, Dr. Georgi Stranski University Hospital, Quironsalud Madrid University Hospital, State University of New York - Upstate Medical University

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---